Literature DB >> 30263570

Caulerpa lentillifera inhibits protein-tyrosine phosphatase 1B and protects pancreatic beta cell via its insulin mimetic effect.

Bhesh Raj Sharma1, Hyun Jung Kim2, Dong Young Rhyu1.   

Abstract

The aim of this study was to determine whether Caulerpa lentillifea extract (CLE) can protect pancreatic beta cells and enhance insulin signaling in adipocytes. We measured the protein tyrosine phosphatase (PTP)-1B inhibitory effect of CLE using an in-vitro enzyme assay. Proteins involved in the pancreatic beta-cell death and insulin signaling were measured by western blotting. Oil-red O staining was used to measure the insulin mimetic effect of CLE. CLE strongly inhibited the PTP1B enzyme. In rat insulinoma (RIN)-m5F cells, CLE decreased the activation of extracellular regulated kinase (ERK)-1/2, P38 mitogen activated protein kinase (P38), c-Jun NH2-terminal kinase (JNK), and nuclear factor kappa-light-chain-enhancer of the activated B cells (NF-κB). Furthermore, CLE showed insulin-mimetic effect and enhanced the activation of insulin-signaling molecules including IRS, AKT, PI3K, and GSK-3β in 3T3-L1 adipocytes. Our results suggested that CLE-inhibited PTP1B, protected the pancreatic beta cells, and enhanced insulin sensitization in the adipocytes.

Entities:  

Keywords:  Caulerpa lentillifera; adipocytes; insulin signaling; pancreatic beta cells; protein tyrosine phosphatase (PTP)-1B

Year:  2017        PMID: 30263570      PMCID: PMC6049453          DOI: 10.1007/s10068-017-0068-4

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  15 in total

1.  Antihyperglycemic effect of crude extracts of some Egyptian plants and algae.

Authors:  Sameh Fekry AbouZid; Osama Mohamed Ahmed; Rasha Rashad Ahmed; Ayman Mahmoud; Ehab Abdella; Mohamed Badr Ashour
Journal:  J Med Food       Date:  2014-01-09       Impact factor: 2.786

2.  Anti-diabetic effects of Caulerpa lentillifera: stimulation of insulin secretion in pancreatic β-cells and enhancement of glucose uptake in adipocytes.

Authors:  Bhesh Raj Sharma; Dong Young Rhyu
Journal:  Asian Pac J Trop Biomed       Date:  2014-07

Review 3.  Natural products: a continuing source of novel drug leads.

Authors:  Gordon M Cragg; David J Newman
Journal:  Biochim Biophys Acta       Date:  2013-02-18

Review 4.  Protein tyrosine phosphatase 1B inhibitors for diabetes.

Authors:  Theodore O Johnson; Jacques Ermolieff; Michael R Jirousek
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

5.  Nelumbo Nucifera leaf extract attenuated pancreatic β-cells toxicity induced by interleukin-1β and interferon-γ, and increased insulin secrection of pancreatic β-cells in streptozotocin-induced diabetic rats.

Authors:  Bhesh Raj Sharma; Min Suk Kim; Dong Young Rhyu
Journal:  J Tradit Chin Med       Date:  2016-02       Impact factor: 0.848

Review 6.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

7.  Beta cell dysfunction and insulin resistance.

Authors:  Marlon E Cerf
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-27       Impact factor: 5.555

8.  Antihyperglycemic effect of Annona squamosa hexane extract in type 2 diabetes animal model: PTP1B inhibition, a possible mechanism of action?

Authors:  Joseph Alex Davis; Suchitra Sharma; Shivani Mittra; S Sujatha; Anil Kanaujia; Gyanesh Shukla; Chandrakant Katiyar; B S Lakshmi; Vinay Sheel Bansal; Pradip Kumar Bhatnagar
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

9.  Caulerpa lentillifera extract ameliorates insulin resistance and regulates glucose metabolism in C57BL/KsJ-db/db mice via PI3K/AKT signaling pathway in myocytes.

Authors:  Bhesh Raj Sharma; Hyun Jung Kim; Dong Young Rhyu
Journal:  J Transl Med       Date:  2015-02-15       Impact factor: 5.531

10.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.